Cracking the many
mysteries of HER2 GEA

Angela Bartley, MD, lead author of the HER2 GEA guideline, says she and colleagues concluded from a review of the literature that using biopsy or resection specimens for testing is acceptable. “And if these two are not available, an FNA specimen can be used from the primary or metastatic tumor.”

  Read the full story »

Dr. Angela Bartley

In new era, cannabis testing
a mixed bag

“Right now, we’re telling people if you can do cannabigerol and cannabinol, you have the best chance of identifying recent cannabis use,” says Marilyn A. Huestis, PhD. But other markers need to be studied. “Now the field is developing a lot of cannabis products, including synthetic cannabidiol [CBD], that are high in CBD, and none of these new product formulations have been tested.”

  Read the full story »

Dr. Marilyn Huestis

Buzz, prospects build for heparin-induced thrombocytopenia test

Theodore E. Warkentin, MD, a professor in the Department of Medicine and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, has studied HIT for 25 years. “My own center only performs HIT assays on Tuesdays and Thursdays, with results reported on Wednesdays and Fridays,” he says. “And I should note that McMaster does the SRA testing for all of Canada, a country of 35 million people.”

  Read the full story »

Dr. Theodore Warkentin

‘Brave’ new book—AP quality management for everyone

What does it take to produce and edit the first book on AP quality management that the CAP has published in more than a decade? A diverse network of experts, a commitment to comprehensive quality assurance, and, says co-editor Qihui “Jim” Zhai, MD, a bit of bravery. “We all talk about professional mistakes, but we don’t want to talk about them in public,” Dr. Zhai says.

  Read the full story »

Dr. Qihui Zhai

THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2016

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2016

MARKETPLACE

New pathology lab products and industry news

JOB POSTINGS

» Search for jobs
» Post open positions

CAP TODAY WEBINARS ON DEMAND

» NEW: Respiratory Pathogen Detection: An outcome-based study on a first in, first out (FIFO) testing algorithm.
» All on-demand webinars

PRODUCT GUIDES

» Compare products side-by-side
» Download product guide PDFs

MAGAZINE ISSUE ARCHIVE

» 2013–2016 article index
» 2000–2012 article index

CAP TODAY RECOMMENDS

» POC testing management and integration
A new white paper from Orchard Software titled “Point-of-care Testing: The Great Boom Ahead” discusses the history of POC testing connectivity and shares specific case study savings and improvements associated with the adoption of a POC testing connectivity and management solution. Read the white paper.

» Learn about molecular testing for M. pneumoniae
Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch.

» The CPOE Lab Test: Utilization Opportunity
This editorial is brought to you through Roche’s Lab Leaders initiative.

» The future of the lab in health care
CAP TODAY publisher Bob McGonnagle gathered with Orchard Software executives to discuss what lies ahead for laboratories.

SHOW MORE 2017 EVENTS

X